GI-ProBalance® Is Issued a New Patent in Australia!

Print Friendly

It’s time to celebrate! A new patent has been issued in Australia for the technology pertaining to Mannatech’s GI-ProBalance product formulation.

The patent was issued on March 7, 2013 and is valid for 20 years from the international filing date (Mary 8, 2008), expiring on May 9, 2028.

What does it mean for a product to have a patent?

The ingredients and formulation of GI-ProBalance cannot be copied by anyone for 20 years from the issued date. This means that GI-ProBalance remains exclusive to our Mannatech® community.

To date, Mannatech holds four patents for the technology related to our GI-ProBalance formulation. Our total patent portfolio includes 85 patents worldwide for the technology pertaining to our Ambrotose®, Ambrotose AO®, PhytoMatrix®, and GI-ProBalance product formulations and three patents in the field of rapid serum and rapid Saccharide biomarker assays.

All this is to say that things are looking up for Associates Down Under!

NOTE: U.S. product is featured in the photo.

What did you think about this article?

Tell us your thoughts in the comment section below.

Leave a Comment

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

You may also like...